Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vatalanib in imatinib-resistant GIST
NCT00117299Phase 2Completed
- Sponsor
- University of Helsinki
- Start
- Sep 2004
- Primary completion
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vatalanib in gastrointestinal stromal tumor (GIST), sponsored by University of Helsinki. Started Sep 2004; status: completed.
02
Drugs
vatalanib
03
Conditions
gastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on NCT00117299.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00117299.